title: Cyclic AMP decreases chemotaxis, invasiveness and lung colonization of H-ras transformed mouse fibroblasts.
abstract: We transfected mouse 10T1/2 fibroblasts with the H-ras oncogene and isolated lines expressing H-ras. One of the lines exhibited a highly malignant phenotype with the ability to produce large tumors and to colonize the lung after tail vein injection. In addition, the cells of this line showed increased collagenase IV production, directed migration and invasiveness, properties associated with the ability of tumor cells to metastasize. Since cyclic adenosine 3',5'-monophosphate (cAMP) is known to down-regulate ras expression, we exposed the malignant cells (Cl-1) to either N6, 2',0-dibutyryl cAMP (DB-cAMP) or 8-bromo cAMP (8-Br-cAMP), either with or without a phosphodiesterase inhibitor. We found that these treatments reduced the expression of ras, chemotaxis, invasiveness, and lung colonization of the ras-transformed cells. We therefore postulate that the malignancy of some cells may be regulated by alterations in the intracellular cAMP levels by suppressing ras expression and/or by reducing other activities required for the dissemination of tumor cells.
authors.affiliation: Laboratory of Developmental Biology, National Institute of Dental Research, National Institutes of Health, Bethesda.
authors.forename: Y
authors.initials: Y
authors.lastname: Iwamoto
authors.forename: R
authors.initials: R
authors.lastname: Reich
authors.forename: G
authors.initials: G
authors.lastname: Nemeth
authors.forename: Y
authors.initials: Y
authors.lastname: Yamada
authors.forename: G R
authors.initials: GR
authors.lastname: Martin
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D002633:Chemotaxis / Q000187:drug effects*; D003094:Collagen; D017364:Collagenases / Q000378:metabolism; D004338:Drug Combinations; D005260:Female; D005347:Fibroblasts; D015870:Gene Expression / Q000187:drug effects; D011905:Genes, ras; D066298:In Vitro Techniques; D007797:Laminin; D008175:Lung Neoplasms / Q000473:pathology; D051379:Mice; D008819:Mice, Nude; D009374:Neoplasms, Experimental / Q000473:pathology; D011509:Proteoglycans; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics / Q000494:pharmacology*; D014162:Transfection
chemical_list: D004338:Drug Combinations; D007797:Laminin; D011509:Proteoglycans; C059485:matrigel; D015124:8-Bromo Cyclic Adenosine Monophosphate; D003994:Bucladesine; D003094:Collagen; D017364:Collagenases; D016283:Proto-Oncogene Proteins p21(ras); D015056:1-Methyl-3-isobutylxanthine